MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin
Crossref DOI link: https://doi.org/10.1007/s13402-017-0325-9
Published Online: 2017-05-31
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhao, Han
Xie, Yu-Zhuo
Xing, Rui
Sun, Ming
Chi, Feng
Zeng, Yue-Can
License valid from 2017-05-31